Counterbalancing risks and gains from extended resections in malignant glioma surgery: A supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 3, 2011, Pages 613-623

  Stummer, Walter ^a   Tonn, Jörg Christian ^b   Mehdorn, Hubertus Maximilian ^c   Nestler, Ulf ^d   Franz, Kea ^e   Goetz, Claudia ^b   Bink, Andrea ^e   Pichlmeier, Uwe ^f  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY HOSPITAL GIESSEN   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f MEDAC GMBH   (Germany)

Author keywords

5 aminolevulinic acid; Malignant glioma; Resection; Surgical risk

Indexed keywords

AMINOLEVULINIC ACID; DEXAMETHASONE; STEROID; TEMOZOLOMIDE;

ADULT; AGED; APHASIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CONTRAST ENHANCEMENT; CONVULSION; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; FEMALE; FLUORESCENCE GUIDED MICROSURGERY; GLIOBLASTOMA; GRAND MAL SEIZURE; HEMIPARESIS; HUMAN; INTENTION TO TREAT ANALYSIS; INTRACRANIAL HYPERTENSION; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SPEECH DISORDER; STEROID THERAPY; STUPOR; THERAPY EFFECT; TREATMENT RESPONSE; TUMOR VOLUME; WHITE LIGHT MICROSURGERY;

ADULT; AGED; AMINOLEVULINIC ACID; ANTI-INFLAMMATORY AGENTS; BRAIN NEOPLASMS; CONSCIOUSNESS DISORDERS; DEXAMETHASONE; ENDPOINT DETERMINATION; FEMALE; FLUORESCENCE; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUROSURGICAL PROCEDURES; PHOTOSENSITIZING AGENTS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK ASSESSMENT; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952272293     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.3.JNS097     Document Type: Article

References (14)

1. Albanese MA, Clarke WR, Adams HP Jr, Woolson RF: Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke 25:1746-1751, 1994 (Pubitemid 24274965)
2. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45-61, 1994 (Pubitemid 24015065)
3. Barker FG II, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, et al: Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 84:442-448, 1996 (Pubitemid 26062869)
4. Chang SM, Parney IF, McDermott M, Barker FG II, Schmidt MH, Huang W, et al: Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175-1181, 2003 (Pubitemid 36617917)
5. Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH stroke scale. Arch Neurol 46:660-662, 1989 (Pubitemid 19150945)
6. Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G III, Erickson RK, Hekmatpanah J, et al: Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41:1028-1038, 1997 (Pubitemid 27475463)
7. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001 (Pubitemid 32799739)
8. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280, 1990 (Pubitemid 20195640)
9. Pichlmeier U, Bink A, Schackert G, Stummer W: Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025-1034, 2008
10. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
11. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al: Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564-576, 2008
12. Van den Bent MJ, Stupp R, Mason W, Mirimanoff RO, Lacombe D, Gorlia T: Impact of the extent of resection on overall survival in newly-diagnosed glioblastoma afer chemo-irradiation with temozolamide: further analysis of EORTC study 26981. Eur J Cancer Suppl 3:134, 2005 (Abstract)
13. Wityk RJ, Pessin MS, Kaplan RF, Caplan LR: Serial assessment of acute stroke using the NIH Stroke Scale. Stroke 25:362-365, 1994 (Pubitemid 24047260)
14. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, et al: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588-593, 2000 (Pubitemid 30636298)